1. Home
  2. BMEA vs SSTI Comparison

BMEA vs SSTI Comparison

Compare BMEA & SSTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

N/A

Current Price

$1.73

Market Cap

115.2M

Sector

Health Care

ML Signal

N/A

Logo SoundThinking Inc.

SSTI

SoundThinking Inc.

HOLD

Current Price

$6.20

Market Cap

99.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMEA
SSTI
Founded
2017
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
115.2M
99.7M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
BMEA
SSTI
Price
$1.73
$6.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
4
Target Price
$9.83
$15.00
AVG Volume (30 Days)
1.4M
169.8K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
69.19
N/A
EPS
N/A
N/A
Revenue
N/A
$34,753,000.00
Revenue This Year
N/A
$7.43
Revenue Next Year
N/A
$6.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
46.25
52 Week Low
$0.87
$5.52
52 Week High
$2.99
$13.29

Technical Indicators

Market Signals
Indicator
BMEA
SSTI
Relative Strength Index (RSI) 75.92 38.11
Support Level $1.23 $6.09
Resistance Level $1.69 $7.04
Average True Range (ATR) 0.11 0.35
MACD 0.04 -0.03
Stochastic Oscillator 72.03 26.46

Price Performance

Historical Comparison
BMEA
SSTI

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

About SSTI SoundThinking Inc.

SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes: ShotSpotter, the acoustic gunshot detection system; CrimeTracer, the foremost law enforcement search engine; CaseBuilder, a one-stop investigation management system; ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact; PlateRangerTM powered by Rekor, an automatic license plate recognition ("ALPR") and vehicle identification solution; SafePointe, an AI-based weapons detection system.

Share on Social Networks: